WO2003095644A1 - Nouvelles proteines et adn pour lesdites proteines - Google Patents

Nouvelles proteines et adn pour lesdites proteines Download PDF

Info

Publication number
WO2003095644A1
WO2003095644A1 PCT/JP2003/005941 JP0305941W WO03095644A1 WO 2003095644 A1 WO2003095644 A1 WO 2003095644A1 JP 0305941 W JP0305941 W JP 0305941W WO 03095644 A1 WO03095644 A1 WO 03095644A1
Authority
WO
WIPO (PCT)
Prior art keywords
diseases
seq
protein
amino acid
acid sequence
Prior art date
Application number
PCT/JP2003/005941
Other languages
English (en)
French (fr)
Inventor
Atsushi Nakanishi
Hiroyuki Miya
Toshi Iwama
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Priority to US10/514,258 priority Critical patent/US20050208494A1/en
Priority to EP03749815A priority patent/EP1505150A1/en
Priority to AU2003234914A priority patent/AU2003234914A1/en
Publication of WO2003095644A1 publication Critical patent/WO2003095644A1/ja

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
PCT/JP2003/005941 2002-05-14 2003-05-13 Nouvelles proteines et adn pour lesdites proteines WO2003095644A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/514,258 US20050208494A1 (en) 2002-05-14 2003-05-13 Novel proteins and dnas thereof
EP03749815A EP1505150A1 (en) 2002-05-14 2003-05-13 Novel proteins and dnas thereof
AU2003234914A AU2003234914A1 (en) 2002-05-14 2003-05-13 Novel proteins and dnas thereof

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2002139184 2002-05-14
JP2002-139184 2002-05-14
JP2002157669 2002-05-30
JP2002-157669 2002-05-30
JP2002218324 2002-07-26
JP2002-218324 2002-07-26

Publications (1)

Publication Number Publication Date
WO2003095644A1 true WO2003095644A1 (fr) 2003-11-20

Family

ID=29424256

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/005941 WO2003095644A1 (fr) 2002-05-14 2003-05-13 Nouvelles proteines et adn pour lesdites proteines

Country Status (4)

Country Link
US (1) US20050208494A1 (ja)
EP (1) EP1505150A1 (ja)
AU (1) AU2003234914A1 (ja)
WO (1) WO2003095644A1 (ja)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048787A1 (en) * 2000-06-14 2002-04-25 Ming-Hui Wei Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002040649A1 (en) * 2000-11-15 2002-05-23 Icagen, Inc. Slo2 and slo4, novel potassium channel proteins from human brain
WO2002055701A2 (en) * 2000-12-15 2002-07-18 Millennium Pharm Inc Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof
WO2002077237A2 (en) * 2001-02-09 2002-10-03 Incyte Genomics, Inc. Transporters and ion channels

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048787A1 (en) * 2000-06-14 2002-04-25 Ming-Hui Wei Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002040649A1 (en) * 2000-11-15 2002-05-23 Icagen, Inc. Slo2 and slo4, novel potassium channel proteins from human brain
WO2002055701A2 (en) * 2000-12-15 2002-07-18 Millennium Pharm Inc Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof
WO2002077237A2 (en) * 2001-02-09 2002-10-03 Incyte Genomics, Inc. Transporters and ion channels

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOINER W.J. ET AL.: "Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits", NATURE NEUROSCI., vol. 1, no. 6, 1998, pages 462 - 469, XP001088042 *

Also Published As

Publication number Publication date
US20050208494A1 (en) 2005-09-22
EP1505150A1 (en) 2005-02-09
AU2003234914A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
EP1361229A3 (en) Use of Tyrosine Kinase (PYK2) to produce antibodies
IL145535A0 (en) Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
WO2003066859A3 (en) Amino acid sequences capable of facilitating penetration across a biological barrier
AU2001272735A1 (en) Novel physiologically active peptide and use thereof
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
WO2002061076A1 (en) Adiponectin-associated protein
IL135688A0 (en) Human checkpoint kinase, hcds1, compositions and methods
WO2006028561A3 (en) Novel purified fabi polypeptides from fransicella tularensis
WO2007093848A3 (en) Crystalline enoyl-(acyl-carrier-protein) reductase from heliobacter pylori
EP1741792A4 (en) NEW LIGAND OF A G-PROTEIN-CONJUGATED RECEPTOR PROTEIN AND USE THEREOF
WO1998011234A3 (en) Human protein kinases
EP1044605A4 (en) GENUTUTED ANIMALS
WO2003076658A3 (en) A susceptibility gene for late-onset idiopathic parkinson's disease
WO2003095644A1 (fr) Nouvelles proteines et adn pour lesdites proteines
WO2008153072A1 (ja) 骨・関節疾患感受性遺伝子およびその用途
AU2003202489A1 (en) Screening method
EP1634951A4 (en) NEW PROTEIN
WO2003022300A1 (fr) Remedes prophylactiques et curatifs contre les maladies des os et des articulations
EP0855442A3 (en) Central nervous system transcription regulator polypeptide and a DNA sequence to which a protein containing the polypeptide binds
WO2003070770A3 (en) Engineered human kunitz-type protease inhibitor
WO2002062998A1 (fr) Nouvelle proteine et son adn
WO2004042043A3 (en) Crystal structures of bacterial ribulose-phosphate 3-epimerases
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
WO2004050703A8 (en) Splice variant of the human pituitary growth hormone
WO2003087352A3 (en) Enolase polypeptides and structures

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003749815

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10514258

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2003749815

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2003749815

Country of ref document: EP